OptimizeRx Corporation (OPRX)

NASDAQ: OPRX · Real-Time Price · USD
7.17
+0.53 (7.98%)
At close: Apr 17, 2026, 4:00 PM EDT
7.23
+0.06 (0.84%)
After-hours: Apr 17, 2026, 7:42 PM EDT
Market Cap134.52M -12.6%
Revenue (ttm)109.43M +18.8%
Net Income5.13M
EPS0.27
Shares Out 18.76M
PE Ratio26.56
Forward PE7.61
Dividendn/a
Ex-Dividend Daten/a
Volume518,889
Open6.74
Previous Close6.64
Day's Range6.74 - 7.29
52-Week Range5.54 - 22.25
Beta1.28
AnalystsStrong Buy
Price Target16.67 (+132.5%)
Earnings DateMay 11, 2026

About OPRX

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program... [Read more]

Sector Healthcare
Founded 2006
Employees 133
Stock Exchange NASDAQ
Ticker Symbol OPRX
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for OPRX stock is "Strong Buy." The 12-month stock price target is $16.67, which is an increase of 132.50% from the latest price.

Price Target
$16.67
(132.50% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

OptimizeRx Appoints Mary Varghese Presti to Board of Directors

Microsoft Health & Life Sciences COO brings expertise in scaling healthcare platforms, commercializing new technologies, and driving operational efficiency Microsoft Health & Life Sciences COO brings ...

11 days ago - GlobeNewsWire

OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty

OptimizeRx Corp (NASDAQ: OPRX) shares are tumbling on Friday as the company faces increased market volatility and uncertainty surrounding Most Favored Nation (MFN) pricing.

6 weeks ago - Benzinga

UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results

WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and enga...

6 weeks ago - GlobeNewsWire

OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results

WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and enga...

6 weeks ago - GlobeNewsWire

OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET

WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

2 months ago - GlobeNewsWire

OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing

WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life science companies reach and engage...

3 months ago - GlobeNewsWire

OptimizeRx Continues Expansion of the Company's Point-Of-Care Network

WALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

4 months ago - GlobeNewsWire

OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance

-   Q3 revenue of $26.1 million, increased 22% year-over-year-   Q3 gross profit increased 30% year-over-year to $17.5 million-   Increases full year 2025 guidance to a revenue range between $105 mill...

5 months ago - GlobeNewsWire

OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET

WALTHAM, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

6 months ago - GlobeNewsWire

OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference

WALTHAM, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and enga...

7 months ago - GlobeNewsWire

OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising

Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood ® Targeting Data with Lamar's Vast Nationwide OOH Network to  Strengthen OOH Media for Healthcare Marketing

7 months ago - GlobeNewsWire

OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth

WALTHAM, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

8 months ago - GlobeNewsWire

OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

WALTHAM, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

9 months ago - GlobeNewsWire

OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET

WALTHAM, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

9 months ago - GlobeNewsWire

OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors

WALTHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engag...

10 months ago - GlobeNewsWire

Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions

CANNES, France--(BUSINESS WIRE)-- #TV--Simulmedia announced a strategic partnership with OptimizeRx Corp. to enable the self-serve availability of Micro-Neighborhood® Targeting (MNT).

10 months ago - Business Wire

OptimizeRx to Participate in Upcoming Investor Conferences

WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage...

1 year ago - GlobeNewsWire

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage...

1 year ago - GlobeNewsWire

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report

WALTHAM, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage...

1 year ago - GlobeNewsWire

OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET

WALTHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and enga...

1 year ago - GlobeNewsWire

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

WALTHAM, Mass., April 18, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and enga...

1 year ago - GlobeNewsWire

OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million

OPTIMIZERx Corp. OPRX, a health care technology firm, reported on Wednesday fourth-quarter sales of $32.32 million, up 14% year-over-year, beating the consensus of $30.36 million.

1 year ago - Benzinga

OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results

WALTHAM, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and enga...

1 year ago - GlobeNewsWire

OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations

WALTHAM, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and enga...

1 year ago - GlobeNewsWire

OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer

Silvestro has a demonstrated record of accelerating revenue growth, expanding brand relevance, and building a market-leading team Silvestro has a demonstrated record of accelerating revenue growth, ex...

1 year ago - GlobeNewsWire